Home Cart Sign in  
Chemical Structure| 1622921-15-6 Chemical Structure| 1622921-15-6

Structure of Remodelin HBr
CAS No.: 1622921-15-6

Chemical Structure| 1622921-15-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Remodelin hydrobromide is a selective inhibitor of acetyl-transferase protein NAT10.

Synonyms: Remodelin hydrobromide; Remodelin (hydrobromide)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Remodelin HBr

CAS No. :1622921-15-6
Formula : C15H15BrN4S
M.W : 363.28
SMILES Code : N#CC1=CC=C(C2=CSC(N/N=C3CCCC/3)=N2)C=C1.[H]Br
Synonyms :
Remodelin hydrobromide; Remodelin (hydrobromide)
MDL No. :MFCD28137688
InChI Key :XNWBCMSPDCSWSD-UHFFFAOYSA-N
Pubchem ID :86280479

Safety of Remodelin HBr

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Remodelin HBr

epigenetics

Isoform Comparison

Biological Activity

Description
Remodelin is an orally active and selective inhibitor of acetyltransferase NAT10. Remodelin inhibits NAT10 activitity and slows DNA replication and suppresses growth of prostate cancer cells.Additionally, Remodelin curtails the development of prostate cancer and hepatocellular carcinoma in xenograft models and prolongs the lifespan in models of Hutchinson-Gilford Progeria Syndrome (HGPS)[1].[2].[3].[4].

In Vitro:

Cell Line
Concentration Treated Time Description References
mouse cardiomyocytes 2.5 μM 24 hours Remodelin inhibited the proliferation of mouse cardiomyocytes. PMC10923914
HL1 cells 2.5 μM 24 hours Remodelin inhibited the proliferation of HL1 cells. PMC10923914
AC16 cells 2.5 μM 24 hours Remodelin inhibited the proliferation of AC16 cells. PMC10923914
SW620 20 µM 24 hours To evaluate the inhibitory effect of Remodelin on CRC cell proliferation, the results showed that Remodelin significantly inhibited the proliferation of SW620 and SW48 cells. PMC11792579
SW48 20 µM 24 hours To evaluate the inhibitory effect of Remodelin on CRC cell proliferation, the results showed that Remodelin significantly inhibited the proliferation of SW620 and SW48 cells. PMC11792579
cardiomyocytes 40 μM 24 hours To test the effect of Remodelin on cardiomyocytes PMC11002668
4T1 cells 70 µM 24 hours To investigate the effect of Remodelin on the migration of 4T1 cells, results showed that Remodelin significantly inhibited the migration of 4T1 cells. PMC11451012
BT549 cells 70 µM 24 hours To investigate the effect of Remodelin on the migration of BT549 cells, results showed that Remodelin significantly inhibited the migration of BT549 cells. PMC11451012
MDA-MB-468 cells 70 µM 24 hours To investigate the effect of Remodelin on the migration of MDA-MB-468 cells, results showed that Remodelin significantly inhibited the migration of MDA-MB-468 cells. PMC11451012
SW480 cells 20 μM 48 hours Remodelin inhibited the binding of NAT10 to KIF23 mRNA and reduced the expression of KIF23 and β-catenin, thereby suppressing the proliferation, migration, and invasion of SW480 cells. PMC9753290
LmnaG609G/G609G mouse skin fibroblasts 1 µM 7 days Remodelin treatment reversed HGPS-induced genomic instability and nuclear shape defects PMC5923383

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice LmnaG609G/G609G mouse model Oral 100 mg/kg Daily from 3 weeks of age until the endpoint Remodelin significantly delayed age-dependent weight loss and improved cardiovascular pathology in HGPS mice PMC5923383
BALB/c Nude mice xenograft tumor models and metastasis models Oral or intraperitoneal 100 mg/kg (oral) or 5 mg/kg (intraperitoneal) once daily for 15 days (oral) or every other day for 4 weeks (intraperitoneal) Remodelin significantly inhibited the growth of xenograft tumors and the metastasis of SW480 cells to the lungs or liver. PMC9753290
C57BL/KaLwRij mice 5TMM3VT myeloma model Intraperitoneal injection 5 mg/kg Twice weekly Remodelin significantly extended the survival period of myeloma mice PMC9366180
Mice apex resection model intraperitoneal injection 25 mg/kg/day daily for 7 consecutive days Remodelin attenuates neonatal heart regeneration. PMC10923914
C57BL/6 mice 4-NQO-induced OSCC mouse model Intraperitoneal injection 5 mg/kg Once every two days for 4 weeks Remodelin significantly inhibited HNSCC tumorigenesis and prolonged the overall survival of mice. PMC10620198
Mice cardiac ischemia-reperfusion injury model Oral gavage 100 mg/kg once daily for 7 days To evaluate the protective effect of Remodelin on cardiac ischemia-reperfusion injury PMC11002668
Balb/c mice 4T1 tumor model Intraperitoneal injection 3 mg/kg Every four days until the end of the experiment To investigate the effect of Remodelin on 4T1 tumor growth, results showed that Remodelin significantly inhibited tumor growth and lung metastasis. PMC11451012
C57BL/6 mice High-fat diet-induced MASLD model Intraperitoneal injection 20 mg/kg Once daily for 16 days Remodelin significantly ameliorated high-fat diet-induced liver steatosis and dyslipidemia, reducing liver inflammation and fibrosis. PMC11462375

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.75mL

0.55mL

0.28mL

13.76mL

2.75mL

1.38mL

27.53mL

5.51mL

2.75mL

References

 

Historical Records

Categories